Rogowski Law

Delaware

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Cases28
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechComp. Arch. and SoftwareMech Eng, Manuf
Top Attorneys
Patrick J. CoyneNeal S. CohenPeter Kinsella
Elite Ratings
DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered
Case
Description
10/08/24
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation
1:21-MD-03017
 (
D. DE
)
STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 10/8/2024 (nms). (Entered: 10/08/2024)
10/08/24
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation
1:21-MD-03017
 (
D. DE
)
SO ORDERED, re [316] STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 10/23/2024). Signed by Judge Richard G. Andrews on 10/8/2024. (nms) (Entered: 10/08/2024)
08/15/24
Astrazeneca Ab v. ScieGen Pharmaceuticals Inc
1:24-CV-00923
 (
D. DE
)
MOTION for Pro Hac Vice Appearance of Attorney Robert Silver - filed by ScieGen Pharmaceuticals, Inc.. (Rogowski, Patricia) (Entered: 08/15/2024)
08/15/24
Astrazeneca Ab v. ScieGen Pharmaceuticals Inc
1:24-CV-00923
 (
D. DE
)
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ScieGen Pharmaceuticals, Inc.. (Rogowski, Patricia) (Entered: 08/15/2024)
08/15/24
Astrazeneca Ab v. ScieGen Pharmaceuticals Inc
1:24-CV-00923
 (
D. DE
)
NOTICE of Appearance by Patricia Smink Rogowski on behalf of ScieGen Pharmaceuticals, Inc. (Rogowski, Patricia) (Entered: 08/15/2024)
08/15/24
Astrazeneca Ab v. ScieGen Pharmaceuticals Inc
1:24-CV-00923
 (
D. DE
)
WAIVER OF SERVICE returned executed by AstraZeneca AB: For ScieGen Pharmaceuticals, Inc. waiver sent on 8/14/2024, answer due 11/12/2024. (Joyce, Alexandra) (Entered: 08/15/2024)
08/15/24
Astrazeneca Ab v. ScieGen Pharmaceuticals Inc
1:24-CV-00923
 (
D. DE
)
Pro Hac Vice Fee - Credit Card Payment received for Robert Silver. ( re 9 MOTION for Pro Hac Vice Appearance of Attorney Robert Silver )( Payment of $ 50, receipt number ADEDC-4476643).(Rogowski, Patricia) (Entered: 08/15/2024)
08/15/24
Astrazeneca Ab v. ScieGen Pharmaceuticals Inc
1:24-CV-00923
 (
D. DE
)
SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Robert Silver, filed by ScieGen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 8/15/2024. (nms) (Entered: 08/15/2024)
05/03/23
Bayer IP GmbH v. ScieGen Pharma Inc
1:23-CV-00335
 (
D. DE
)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 05/03/2023)
05/03/23
Bayer IP GmbH v. ScieGen Pharma Inc
1:23-CV-00335
 (
D. DE
)
SO ORDERED Granting (D.I. 151 in 21-md-3017-RGA; D.I. 11 in 23-cv-335-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 5/3/2023. Associated Cases: 1:23-cv-00335-RGA, 1:21-md-03017-RGA(nms) (Entered: 05/03/2023)